Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Byetta vs. Ozempic

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Exenatide (Byetta, Bydureon BCise) and semaglutide (Ozempic) are both medications in the glucagon-like peptide-1 (GLP-1) receptor agonist class used to treat Type 2 diabetes. They help control blood sugar levels by mimicking the GLP-1 hormone, which increases insulin release and reduces sugar production in the liver. Exenatide is available in short-acting, twice-daily injection (Byetta) and long-acting, once weekly (Bydureon BCise) forms, while semaglutide is a long-acting medication given once a week. Exenatide is approved for use in adults and children 10 years and older (Bydureon BCise), whereas semaglutide is only approved for adults. Semaglutide also has the added benefit of reducing the risk of heart attack, stroke, and death in adults with Type 2 diabetes and heart disease. Common side effects for both medications include nausea, vomiting, and diarrhea. Both medications carry a risk of thyroid cancer and pancreatitis. Exenatide is available as a lower-cost generic, while semaglutide is only available as a brand-name medication.

  • Exenatide
    Ozempic (semaglutide)
  • Exenatide
    Ozempic (semaglutide)

  • Summary of Byetta vs. Ozempic

    Summary for GLP-1 agonist
    Prescription only

    Exenatide is an injectable medication used to lower blood sugar in people with type 2 diabetes. It should be used along with an appropriate diet and exercise plan. This medication comes in short-acting (Byetta) and long-acting (Bydureon BCise) versions.

    Summary for GLP-1 agonist
    Prescription only

    Ozempic (semaglutide) is a prescription injection used with diet and exercise to help manage Type 2 diabetes in adults. It's also FDA approved to lower the risk of heart attack, stroke, and heart-related death in those with Type 2 diabetes and heart disease. In addition, it can reduce the risk of worsening kidney problems in people with Type 2 diabetes and chronic kidney disease (CKD). Ozempic (semaglutide) is a GLP-1 agonist that's injected under the skin once a week. Common side effects include nausea, vomiting, and diarrhea.

  • Indications of Byetta vs. Ozempic

    Indications for
    •Type 2 diabetes, in combination with diet and exercise (adults) - Byetta only
    •Type 2 diabetes, in combination with diet and exercise (adults and children age 10 years and older) - Bydureon BCise only
    Indications for
    •Type 2 diabetes
    •Lower the risk of heart attack, stroke, and heart-related death in adults with Type 2 diabetes and heart disease
    •Lower the risk of worsening kidney problems and heart-related death in adults with Type 2 diabetes and chronic kidney disease (CKD)

  • Pros and Cons of Byetta vs. Ozempic

    Pros and Const for GLP-1 agonist
    Pros
    •Can lower your A1c (average blood sugar over time)
    •Not as likely to cause very low blood sugar as other diabetes medications
    •Might help some people with weight loss
    •Bydureon BCise (once-weekly injections) can be taken any time of day, with or without food
    Cons
    •Slows stomach emptying, which can affect how other medications are absorbed
    •Short-acting version (Byetta) must be used within 60 minutes before meals
    •Not safe for people with severe kidney problems
    •Brand-name only, so it can be expensive
    Pros and Const for GLP-1 agonist
    Pros
    •Only given once per week
    •Might help you lose weight
    •Helps lower the risk of heart problems and kidney problems in people with type 2 diabetes
    •Can store open and used pens at room temperature for up to 8 weeks
    Cons
    •Is an injection given under the skin
    •Commonly causes nausea, vomiting, and diarrhea
    •Risk of low blood sugar if taken with certain diabetes medications
    •Can't be used for Type 1 diabetes

  • Common Side Effects of Byetta vs. Ozempic

    Common Side Effects for
    •Nausea (Up to 44%)
    •Vomiting (Up to 18%)
    •Diarrhea (Up to 18%)
    •Headache (Up to 14%)
    •Injection-site lump (11%)
    •Constipation (Up to 10%)

    Note: These side effects were reported by people taking either exenatide alone or with other diabetes medications. The side effects you experience might differ depending on what other diabetes medications you're taking.

    Common Side Effects for
    •Nausea (16-20%)
    •Diarrhea (9%)
    •Vomiting (5-9%)
    •Stomach pain (6-7%)
    •Constipation (3-5%)

  • Warnings of Byetta vs. Ozempic

    Common Side Effects for
    •Thyroid cancer - Bydureon BCise only
    •Inflammation of the pancreas (pancreatitis)
    •Low blood sugar (hypoglycemia)
    •Kidney problems
    •Severe allergic reactions
    •Severe bleeding
    •Injection-site reactions
    •Gallbladder problems
    Common Side Effects for
    •Risk of thyroid tumors
    •Inflammation of the pancreas (pancreatitis)
    •Eye problems
    •Low blood sugar (hypoglycemia) when taken with certain diabetes medications
    •Kidney damage
    •Severe stomach problems
    •Severe allergic reactions
    •Gallbladder problems
    •Lung problems during anesthesia or deep sedation

  • Prices with our coupons for Byetta vs. Ozempic

    Learn more about Exenatide
    Learn more about Ozempic

Compare other Diabetes Type 2 and Management with Incretin-based Therapies drugs

Byetta vs OzempicGlucotrol vs ByettaGlyburide vs ByettaJanuvia vs ByettaMetaglip vs ByettaNesina vs ByettaOnglyza vs ByettaTrulicity vs ByettaVictoza vs ByettaAlogliptin vs JanuviaFarxiga vs GlucotrolGlucotrol vs ActosGlucotrol vs AfrezzaGlucotrol vs AmarylGlucotrol vs GlucovanceGlucotrol vs JanumetGlucotrol vs VictozaGlyxambi vs JanuviaJanuvia vs ActosJanuvia vs AfrezzaJanuvia vs AmarylJanuvia vs FarxigaJanuvia vs GlipizideJanuvia vs GlucotrolJanuvia vs GlucovanceJanuvia vs InvokanaJardiance vs GlucotrolNesina vs GlucotrolToujeo vs GlucotrolTradjenta vs Glucotrol
View More

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.